Ursula B. Bartels
General Counsel at Medarex, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Galik | M | - |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 15 years |
| Jeremy Levin | M | 70 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | - |
| David T. Bonk | M | - |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 15 years |
| James Ford | M | - | 29 years | |
| Sandra Leung | F | 63 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 15 years |
| Charles Sigal | M | 72 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | - |
| Carlo de Notaristefani | M | 67 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 15 years |
| Anthony A. McBride | M | 60 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 15 years |
| Thomas K. Kaney | M | - |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | - |
| Brian Daniels | M | 65 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 15 years |
| Laura S. Choi | F | - |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | - |
| Sonia Vora | F | - |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | - |
| David Redfern | M | 57 | 30 years | |
| Paul von Autenried | M | 62 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | - |
| Graham Rivers | M | - | 26 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Howard H. Pien | M | 66 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 15 years |
| D. Alan Quarterman | M | - |
University of Virginia
| 8 years |
| J. Carroll | M | 74 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 9 years |
| Jack Goldstein | M | 77 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 4 years |
| Irwin Lerner | M | 93 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 14 years |
| Thurgood Marshall | M | 67 |
University of Virginia
| 7 years |
| Geoffrey Nichol | M | 69 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 15 years |
| Jeffrey Ferguson | M | 58 |
University of Virginia
| 8 years |
| Don Soland | M | 65 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 11 years |
| Alex Howarth | M | 55 | 10 years | |
| Julian Heslop | M | 70 | 13 years | |
| David Lawrence | M | 61 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 16 years |
| John M. Paris | M | - |
University of Virginia
| 3 years |
| Bob Burke | M | - |
University of Virginia
| 4 years |
| Marc Rubin | M | 69 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 16 years |
| William Louv | M | - | 21 years | |
| Herb A. May | M | - |
University of Virginia
| 4 years |
| Peter Grant | M | - |
University of Virginia
| - |
| Andrew Schwab | M | - |
University of Virginia
| 11 years |
| Scott Coiante | M | 57 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 8 years |
| John W. Bateman | M | - |
University of Virginia
| 7 years |
| Michael Herrman | M | 56 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 16 years |
| Thomas Frame | M | - |
University of Virginia
| 4 years |
| Christopher Viehbacher | M | 64 | 20 years | |
| Michèle Barzach | M | - | 7 years | |
| William Barnes Hauptfuhrer | M | 69 |
University of Virginia
| 5 years |
| David Smith | M | 64 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 7 years |
| James A. Nash | M | 73 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 2 years |
| Christian Schade | M | 63 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 9 years |
| Robert Carr | M | - | 26 years | |
| Richard Sykes | M | 79 | 7 years | |
| Brad Young | M | - |
University of Virginia
| 4 years |
| James W. Allen | M | - |
University of Virginia
| 3 years |
| Jacqueline Marlette-Boras | F | - |
University of Virginia
| 4 years |
| Thomas D. Overbay | M | - |
University of Virginia
| 3 years |
| David Pompliano | M | - |
University of Virginia
| 4 years |
| Jane Whitt Sellers | F | - |
University of Virginia
| 3 years |
| Victoria Barnard | F | - |
University of Virginia
| 2 years |
| Laura Ipsen | F | 60 |
University of Virginia
| 4 years |
| Joseph Janney Thomas | M | 59 |
University of Virginia
| 4 years |
| John L. Walker | M | - |
University of Virginia
| 3 years |
| Sean P. Griffiths | M | - |
University of Virginia
| 3 years |
| Rob S. Hull | M | 59 |
University of Virginia
| 4 years |
| William Redd | M | 68 |
University of Virginia
| 3 years |
| Jonathan Clark | M | 65 |
University of Virginia
| 4 years |
| Peter E. Keith | M | - |
University of Virginia
| 3 years |
| Sean Kelleher | M | - |
University of Virginia
| 4 years |
| Kenneth C. Johnson | M | - |
University of Virginia
| 4 years |
| Ernest Mitchell Norville | M | 65 |
University of Virginia
| 2 years |
| Colin P. Derdeyn | M | - |
University of Virginia
| 4 years |
| Tom Newberry | M | - |
University of Virginia
| 4 years |
| Tom Glanville | M | 65 |
University of Virginia
| 4 years |
| Catharine Midkiff | F | 64 |
University of Virginia
| 4 years |
| Shulman John David | M | 61 |
University of Virginia
| 3 years |
| Glenn McGrath | M | - |
University of Virginia
| 4 years |
| John Stathis | M | - |
University of Virginia
| 4 years |
| James H. Carroll | M | - |
University of Virginia
| 3 years |
| Paul K. Wong | M | - |
University of Virginia
| 4 years |
| Steven R. Point | M | - |
University of Virginia
| 4 years |
| Bagley Reid | M | 61 |
University of Virginia
| 4 years |
| Jack E. Fockler | M | 64 |
University of Virginia
| 3 years |
| Robert Smith | M | 65 |
University of Virginia
| 3 years |
| James Simms | M | 64 |
University of Virginia
| 4 years |
| Emmett McLean | M | 69 |
University of Virginia
| 2 years |
| William R. Thierbach | M | - |
University of Virginia
| 4 years |
| Hugh McGuirk | M | - |
University of Virginia
| 4 years |
| Gordon R. Penman | M | - |
University of Virginia
| 3 years |
| Gregory A. McCrickard | M | - |
University of Virginia
| 4 years |
| Steve Hufford | M | - |
University of Virginia
| 3 years |
| Jack Cunningham | M | - |
University of Virginia
| 4 years |
| Jeffrey R. Lindsey | M | - |
University of Virginia
| 4 years |
| Rodney L. Davis | M | - |
University of Virginia
| 4 years |
| John F. Brenner | M | - |
University of Virginia
| 4 years |
| Peter Johann | M | 67 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 4 years |
| L. Robert J. Johnston | M | - |
University of Virginia
| 4 years |
| William J. Whelan | M | - |
University of Virginia
| 4 years |
| Howard A. Kenny | M | - |
University of Virginia
| 3 years |
| Diane L. Prucino | F | - |
University of Virginia
| 3 years |
| Robert Manning Wadsworth | M | 64 |
University of Virginia
| 4 years |
| John Jenkins | M | 58 |
University of Virginia
| 4 years |
| Mark L. Hanson | M | - |
University of Virginia
| 4 years |
| Hans Houser | M | - |
University of Virginia
| 5 years |
| Timothy Naughton | M | 62 |
University of Virginia
| 4 years |
| Paul Voigt | M | 64 |
University of Virginia
| 4 years |
| Michael Maquet | M | - |
University of Virginia
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 90 | 90.00% |
| United Kingdom | 15 | 15.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ursula B. Bartels
- Personal Network
